Gonadotropin Releasing Hormone Agonist versus Human Chorionic Gonadotropin in Patients with PCOS as Trigger of Ovulation

Gonadotropin releasing hormone agonist (GnRHa) versus human chorionic gonadotropin (HCG) for triggering of ovulation in ovarian stimulation cycles in polycystic ovarian syndrome

Gonadotrophine Releasing Hormone Agonist As A Trigger of Ovulation in poly cystic ovary syndrome

Gonadotrophin releasing hormone agonist with low dose human chorionic gonadotrophin co-triggers versus gonadotrophin releasing hormone agonist alone for reducing the risk of ovari

Ovulation Induction Techniques in Women with Polycystic Ovary Syndrome: A Review of literature

A Comparative study between the effect of oxytocin and human chorionic gonadotropin on induction of ovulation

COMPARISON BETWEEN THE GNRH AGONIST AND ANTAGONIST PROTOCOL IN ASSISTED REPRODUCTION DURING CONTROLLED OVARIAN STIMULATION CYCLES

Is Addition of GNRH Agonist to HRT Significant in Improving The Outcome in FTE Transfer Cycles : Randomized Study

The Effect of Dual Trigger of Oocyte Maturation with Gonadotropin-Releasing Hormone Agonist and Low-Dose Human Chorionic Gonadotropin on Pregnancy Rate in Women at Risk of Ovaria

USING GNRH FOR IMPROVING OVARIAN ACTIVITY AND FERTILITY OF EWES DURING BREEDING SEASON.